Internal Medicine, Gastroenterology · Montgomery, AL
NPI
1174785562
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1722 Pine St, Suite 801
Montgomery, AL, 36106
Phone (334) 239-7059
Medicare paid, 2024
$49K
645 services
Medicare patients, 2024
102
Average age 70
Drug cost, 2024
$1.0M
1,178 prescriptions
Company payments, 2024
$10K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viplove Senadhi was code 99215 (office e&m - established), 235 times for 72 patients. In total Viplove Senadhi billed 645 services in 44 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 235 | 72 | $87.23 | $20K |
| 83013 Clinical Chemistry | Office | 59 | 57 | $62.90 | $3,711 |
| 83014 Clinical Chemistry | Office | 58 | 56 | $7.69 | $446 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 37 | 37 | $57.77 | $2,138 |
| 93975 Duplex Scan - Extremity Arteries | Office | 33 | 33 | $155.10 | $5,118 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 13 | $85.24 | $2,557 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 25 | 24 | $65.98 | $1,650 |
| 93306 Echocardiography (TTE/TEE) | Office | 23 | 21 | $105.54 | $2,427 |
| 76536 Ultrasound - Nonspecific | Office | 14 | 12 | $51.09 | $715 |
By year: 2022 $277K for 4,480 services; 2023 $305K for 3,945 services; 2024 $49K for 645 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83013 Clinical Chemistry | 59 | 57 | $62.90 | $3,711 |
| 83014 Clinical Chemistry | 58 | 56 | $7.69 | $446 |
Medicare prescription drug claims, 2024
In 2024, the drug Viplove Senadhi prescribed most often to Medicare patients was Pantoprazole Sodium, with 167 prescriptions and refills. In total Viplove Senadhi wrote 1,178 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 167 | 390 | 95 | $2,415 |
| Famotidine Generic | 124 | 308 | 77 | $2,775 |
| Omeprazole Generic | 77 | 157 | 60 | $1,465 |
| Linzess Linaclotide | 72 | 144 | 37 | $75K |
| Metoclopramide Hcl Generic | 47 | 76 | 23 | $2,067 |
| Xifaxan Rifaximin | 47 | 47 | 17 | $143K |
| Ursodiol Generic | 37 | 101 | 22 | $149K |
| Doxycycline Hyclate Generic | 37 | 37 | 35 | $751 |
| Trulance Plecanatide | 32 | 58 | 17 | $31K |
| Lansoprazole Generic | 31 | 82 | 18 | $1,202 |
| Ondansetron Odt Ondansetron | 31 | 31 | 21 | $580 |
| Relistor Methylnaltrexone Bromide | 20 | 28 | Under 11 | $100K |
| Sucralfate Generic | 20 | 35 | 14 | $2,416 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 18 | 16 | $385 |
| Dexlansoprazole Dr Dexlansoprazole | 16 | 40 | 12 | $5,986 |
Brand drugs: 316 claims; generic drugs: 862 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Viplove Senadhi $10K ($10K in general payments such as food, travel and fees) from 9 companies. The largest payer was Evoke Pharma, Inc. with $9,742.
| Company | Payments | Amount |
|---|---|---|
| Evoke Pharma, Inc. EVOK | 8 | $9,742 |
| Abbvie Inc. ABBV | 6 | $287 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $80.32 |
| Ironwood Pharmaceuticals, Inc IRWD | 1 | $21.49 |
| Intra-Sana Laboratories | 1 | $20.95 |
| Ardelyx, Inc. ARDX | 1 | $20.85 |
| Celgene Corporation BMY | 1 | $18.6 |
| Exact Sciences Corporation EXAS | 1 | $16.6 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $13.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.